Using Patient-Derived Organoids to Predict Locally Advanced or Metastatic Lung Cancer Tumor Response: A Real-World Study

Researchers generated 214 cancer organoids from 107 patients, of which 212 are lung cancer organoids , primarily derived from malignant serous effusions.